Sodium lauryl sulfoacetate

DB13157ApprovedWithdrawnSmall molecule

Sodium lauryl sulfoacetate is a laxative indicated in the treatment of constipation and bowel preparation for rectal endoscopy. Sodium lauryl sulfoacetate is a wetting agent and surfactant used in enema-type laxative products.

Chemical structure of Sodium lauryl sulfoacetate
Primary indication
Sodium lauryl sulfoacetate is not an active pharmacological ingredient in pharmaceutical preparations and so has no official indication.Curator reviewed · 2 structured indications
Formula / weight
C14H27NaO5S · 330.41 g/mol (avg)
First approval
Canada, 2007
Also known as
Lathanol · Lathanol LAL · Sulfoacetic acid dodecyl ester S-sodium salt

Resolves to

Compound
UNIID0Y70F2B9JCAS1847-58-1PubChem23668827
Clinical / RWD
RxNorm314832ATCA06AG11
Structure
InChIKeyUAJTZZNRJCKXJN-UHFFFAOYSA-MSMILES[Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O

What you can answer from here — as of April 02, 2025

2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
9Marketed productsAcross 3 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Sodium lauryl sulfoacetate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In